Publication | Closed Access

Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy

Hematological MalignancyLymphoid NeoplasiaRituximab-containing ChemotherapyOncologyMedicineMalignant Blood DisorderImmunologyCd20 Protein ExpressionImmunotherapyEpigenetic RegulationCell BiologyAdult T-cell Leukemia-lymphomaTumor Microenvironment